BioNTech Investor Day Presentation Deck slide image

BioNTech Investor Day Presentation Deck

BNT312 strengthens crosslinking between T cells and APCs DAPI LEAT Phalloidin Z-projection on the y Z-projection on the x Single Z plane of iDC cocultured with preactivated CD8+ T cells in the presence of Alexa Fluor 647-conjugated DuoBody-CD40.4-1BB (magenta) and LFA-1 (green) antibodies, on the x and y axes the z-stack of the same picture with the relative zoom in. Nuclei were counterstained with Hoechst (blue) BNT312 (Gen1042) is partnered with Genmab based on 50/50 sharing of costs and profits. Muik A, et al. J Immuno Ther Cancer 2022; 10:e004322. Strengthened crosslinking 10 μm Hoechst bsAb-ctris (CD40+ 4-1BB) LFA-1 Hoechst Protein therapeutics DuoBody-CD40x4-1BB 10 μm Representative fluorescent images of cocultures in the presence of DuoBody-CD40.4-1BB or control antibodies. White dashed line = interface between DC and T cell LFA-1 BIONTECH 126
View entire presentation